Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer

NCT03983993 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Advanced Microsatellite Stable Colorectal Carcinoma
Metastatic Microsatellite Stable Colorectal Carcinoma
Microsatellite Stable
RAS Wild Type
Stage IV Colorectal Cancer AJCC v8
MSI-H Colorectal Cancer

Interventions

DRUG: Niraparib
BIOLOGICAL: Panitumumab

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]